$ANGO News

AngioDynamics Announces 2-Yr Results From PRESERVE Pivotal Trial Demonstrating Durable Oncologic Control And Sustained Safety Profile For NanoKnife System In Focal Ablation Of Intermediate-Risk Prostate Cancer

AngioDynamics Files Patent Infringement Lawsuit Against Endovascular Engineering On April 23, 2026; Seeks Damages And Equitable Relief In Lawsuit Against Endovascular Engineering

Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

AngioDynamics Growing, But With More Noise Than The Street Likes

AngioDynamics shares are trading lower. The company reported Q3 financial results and updated its FY26 guidance.

AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance

AngioDynamics, Inc. (ANGO) Q3 2026 Earnings Call Transcript

AngioDynamics, Inc. 2026 Q3 - Results - Earnings Call Presentation

AngioDynamics Raises FY2026 Adj EPS Guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) vs $(0.29) Est; Raises FY2026 Sales Guidance from $312.000M-$314.000M to $313.500M-$315.500M vs $312.881M Est

AngioDynamics Q3 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $78.423M Beat $76.767M Estimate

AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

AngioDynamics Expands European Indications For NanoKnife System To Include Soft Tissue Ablation For Tumors Of Liver, Pancreas, Kidney, And Prostate

DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth

Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?

AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?

AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now

AngioDynamics J.P. Morgan Conference: MedTech Growth Push, Cash-Flow Path, CEO Retirement Plan

AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript